Main competitors
1m. Revenue rev. 4m. EPS revision 4m. Revenue rev. 1y. EPS revision 1y. Revenue rev. Visibility Nbr of analysts
- - - - - -
29
23
29
18
21
21
23
30
28
27
29
25
19
23
15
15
16
19
Average 23
Weighted average by Cap. 25
Other Pharmaceuticals
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!